Trials / Withdrawn
WithdrawnNCT01082601
Catheter Ablation for Atrial Fibrillation and Heart Failure
Pulmonary Vein Isolation for Rhythm Control in Patients With Atrial Fibrillation and Left Ventricular Dysfunction: A Pilot Study
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- St. Luke's-Roosevelt Hospital Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
To compare heart function, symptoms, exercise capacity and quality of life in patients with Congestive Heart Failure (CHF) and Atrial Fibrillation (AF)before and after catheter ablation. Hypothesis: Restoration and maintenance of sinus rhythm by catheter ablation, without the use of antiarrhythmic drugs, in AF and CHF improves heart failure status.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Pulmonary Vein Isolation (PVI) | Subjects with clinical indication for PVI, either paroxysmal or persistent AF failing medical management with rate or rhythm control medications. |
Timeline
- Start date
- 2010-04-01
- Primary completion
- 2012-01-01
- Completion
- 2012-01-01
- First posted
- 2010-03-08
- Last updated
- 2012-10-17
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01082601. Inclusion in this directory is not an endorsement.